Weitere Informationen
- Prof. Ntziachristos, Institut für biologische und Medizinische Bildgebung am Helmholtz Zentrum München, Technische Universität München
- Prof. Weichert, Institut für Pathologie, Technische Universität München
- Prof. Renu Virmani, CVPath Institute, Gaithersburg, USA
- Prof. Alexiou, Institute für Nanotechnologie (SEON), Universität Erlangen
- DZHK translational research project: “Detection of plaque vulnerability with a novel hybrid intravascular NIRF-IVUS imaging system”
- Leducq PlaqOmics Network: “Defining the Roles of Smooth Muscle Cells and Other Extracellular Matrix Producing Cells in Late Stage Atherosclerotic Plaque Pathogenesis”
- European Society of Cardiology (ESC), grants for “Medical Research Innovation”. Systemic vs. Site Targeted Treatment of Neoatherosclerosis
- EU FP7-HEALTH-2010-single-stage: PRESTIGE (PREvention of late Stent Thrombosis by an Interdisciplinary Global European effort).
- IGGSE: “Differential Integrin Activation in the Process of Restenosis and Endothelialization of Human Stents”
- KKF “Differentielle Integrinaktivierung im Restenose – und Reendothelialisierungsprozess humaner Stentimplantate”
- BIOTRONIK SE & Co. KG: Preclinical evaluation of the biodegradable magnesium stent
- BIOTRONIK SE & Co. KG: ISAR-ORSIRO-OCT study
- Medtronic: ISAR-ZES/EES-OCT study
- Joner M ,.., Virmani R. Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and mcp-1. Arterioscler Thromb Vasc Biol. 2007
- Joner M ,.., Virmani R. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma. Arterioscler Thromb Vasc Biol. 2008
- Otsuka F ,.., Joner M. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J. 2015
- Joner M ,.., Virmani R. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008
- Joner M ,.., Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006
- Virmani R ,.., Joner M. Matching human pathology is essential for validating OCT imaging to detect high-risk plaques. Nat Rev Cardiol. 2014
- Otsuka F, Joner M ,.., Narula J. Clinical classification of plaque morphology in coronary disease. Nat Rev Cardiol. 2014
- Yahagi K ,.., Joner M. Neoatherosclerosis: mirage of an ancient illness or genuine disease condition? Eur Heart J. 2015
- Yahagi K ,.., Joner M, Virmani R. Multiple simultaneous plaque erosion in 3 coronary arteries. JACC Cardiovasc Imaging. 2014
- Virmani R, Joner M, Sakakura K. Recent highlights of ATVB: calcification. Arterioscler Thromb Vasc Biol. 2014
- Yahagi K ,.., Joner M. Pathophysiology of superficial femoral artery in-stent restenosis. J Cardiovasc Surg (Torino). 2014
- Otsuka F ,.., Joner M, Virmani R. Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: A pathology study. Atherosclerosis. 2015
- Otsuka F ,.., Joner M, Virmani R. Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol. 2014
- Malle C ,.., Joner M. Tissue characterization after drug-eluting stent implantation using optical coherence tomography. Arterioscler Thromb Vasc Biol. 2013
- Joner M, Giacoppo D, Kastrati A. Molecular multimodality imaging: has a long-standing dream come true? Eur Heart J. 2016
- Joner M, ….Kastrati A. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium). JACC: Cardiovascular Interventions 2018
- Nicol P,…Joner M. Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells. International Journal of Cardiovascular Imaging 2020
- Nicol P…Joner M. Assessment of a pro-healing stent in an animal model of early neoatherosclerosis. Scientific Reports 2020
- Nicol P…Joner M. Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stents. Eurointervention 2020